Steele Capital Management Inc. Takes Position in Danaher Co. (NYSE:DHR)

Steele Capital Management Inc. acquired a new position in Danaher Co. (NYSE:DHR) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,015 shares of the conglomerate’s stock, valued at approximately $235,000.

Other institutional investors have also made changes to their positions in the company. BKM Wealth Management LLC acquired a new position in Danaher in the fourth quarter valued at about $27,000. Wetzel Investment Advisors Inc. bought a new stake in Danaher during the 4th quarter worth about $29,000. OFI Invest Asset Management bought a new position in Danaher during the third quarter worth about $30,000. Rakuten Securities Inc. bought a new stake in shares of Danaher during the fourth quarter worth approximately $36,000. Finally, Financial Connections Group Inc. acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $41,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In related news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total value of $636,280.74. Following the completion of the sale, the senior vice president now directly owns 4,244 shares in the company, valued at $1,029,891.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the sale, the senior vice president now directly owns 4,244 shares in the company, valued at approximately $1,029,891.48. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The disclosure for this sale can be found here. Insiders have sold 106,565 shares of company stock worth $26,641,364 over the last 90 days. 10.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

DHR has been the subject of several analyst reports. Citigroup raised their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. Bank of America raised their price target on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Barclays raised their price target on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 24th. Finally, TD Cowen upped their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $269.64.

Danaher Trading Down 0.4 %

DHR stock traded down $0.99 during trading on Tuesday, reaching $245.83. 581,726 shares of the stock traded hands, compared to its average volume of 2,743,134. The business’s 50 day moving average price is $248.80 and its 200-day moving average price is $231.53. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $259.00. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The firm has a market capitalization of $182.08 billion, a PE ratio of 41.83, a P/E/G ratio of 3.80 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.20. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same period last year, the business posted $2.36 earnings per share. As a group, sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Thursday, March 28th were given a dividend of $0.27 per share. The ex-dividend date was Wednesday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.